Veru (VERU) Return on Equity [ROE] (2009 - 2026)
Veru's Return on Equity [ROE] came in at -70.91% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 100.37 percentage points from -171.28% a year earlier but down 6.09 percentage points from the prior quarter.
Powered by 
Analysis
Veru (VERU) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Veru's Return on Equity [ROE] was -61.92%, up 76.50 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of -1.15 percentage points (FY2020 to FY2025).
- Going back by fiscal year, Return on Equity [ROE] was -138.42% in FY2024 (+43.39 pp), -181.80% in FY2023 (-110.98 pp), -70.83% in FY2022 (-78.84 pp) and 8.01% in FY2021 (+68.78 pp).
- The five-year range for quarterly Return on Equity [ROE] is -594.98% (fiscal Q3 2023) to 4.78% (fiscal Q4 2021).
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +66.13 percentage points over the last seven quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in fiscal Q3 2024 (a gain of 504.67 percentage points), and the weakest in fiscal Q3 2023 (a drop of 557.77 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Veru | 48.87 Mn | -61.41 Mn | - | -70.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -70.91% |
| Mar 31, 2026 | -64.83% |
| Dec 31, 2025 | -106.43% |
| Jun 30, 2025 | -193.17% |
| Mar 31, 2025 | -158.75% |
| Dec 31, 2024 | -129.67% |
| Jun 30, 2024 | -90.31% |
| Mar 31, 2024 | -80.48% |
| Dec 31, 2023 | -175.98% |
| Sep 30, 2023 | -462.02% |
| Jun 30, 2023 | -594.98% |
| Mar 31, 2023 | -383.03% |
| Dec 31, 2022 | -176.33% |
| Sep 30, 2022 | -84.18% |
| Jun 30, 2022 | -37.21% |
| Mar 31, 2022 | -19.40% |
| Dec 31, 2021 | -10.72% |
| Sep 30, 2021 | 4.78% |
| Jun 30, 2021 | -0.09% |
| Mar 31, 2021 | -0.47% |
API Access
Veru Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();